Therapeutic applications of miRNAs in FLT3+ Acute Myeloid Leukemia: Role of miRNA-155
The Fms-like tyrosine kinase 3 (FLT3) mutation, especially FLT3- internal tandem duplications (FLT3-ITD), is common in AML and associated with poor prognosis and resistance to therapy. This study explores an alternative approach by investigating the role of MicroRNA-155 (miR-155) in AML, known for its oncogenic properties. Previous research has linked miR-155 to poor AML prognosis, particularly in
